Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Genetic Services Laboratory, |
RCV001817169 | SCV002064967 | uncertain significance | not specified | 2017-09-01 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV002489869 | SCV002792391 | uncertain significance | X-linked severe congenital neutropenia; Thrombocytopenia 1; Wiskott-Aldrich syndrome | 2022-01-12 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV002489869 | SCV003009571 | uncertain significance | X-linked severe congenital neutropenia; Thrombocytopenia 1; Wiskott-Aldrich syndrome | 2022-03-09 | criteria provided, single submitter | clinical testing | This sequence change replaces proline, which is neutral and non-polar, with serine, which is neutral and polar, at codon 384 of the WAS protein (p.Pro384Ser). The frequency data for this variant in the population databases is considered unreliable, as metrics indicate poor data quality at this position in the gnomAD database. This variant has not been reported in the literature in individuals affected with WAS-related conditions. Experimental studies and prediction algorithms are not available or were not evaluated, and the functional significance of this variant is currently unknown. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Ce |
RCV003883705 | SCV004702881 | likely benign | not provided | 2024-02-01 | criteria provided, single submitter | clinical testing | WAS: BS2 |